Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Financing Activities (2020 - 2025)

Bio Essence has reported Cash from Financing Activities over the past 6 years, most recently at -$1.3 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 181.23% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached -$1.6 million, down 152.39%, while the annual FY2025 figure was -$1.6 million, 152.39% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$1.3 million at Bio Essence, down from -$158232.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $828847.0 in Q2 2021 and troughed at -$1.3 million in Q4 2025.
  • A 5-year average of $57986.6 and a median of $181870.5 in 2022 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: surged 226.5% in 2021 and later tumbled 2789.56% in 2025.
  • Year by year, Cash from Financing Activities stood at $206002.0 in 2021, then plummeted by 31.8% to $140500.0 in 2022, then skyrocketed by 156.31% to $360117.0 in 2023, then plummeted by 225.38% to -$451513.0 in 2024, then crashed by 181.23% to -$1.3 million in 2025.
  • Business Quant data shows Cash from Financing Activities for BIOE at -$1.3 million in Q4 2025, -$158232.0 in Q3 2025, and -$167797.0 in Q2 2025.